EUVIMEDEUVIMED entdecken
Crossref

The Uric Acid Degrading Probiotics MC1 in Quercetin Nanocoatings and Bioactive Polysaccharides Microgels for Anti‐Hyperuricemia and Gut Microenvironment Modulation

Zekun Li, Zhaoxiang Ma, Dongyu Zhao, Albert Poortinga, Xiaoyu Wang, Yuemiao Zhang, Qing Yue, Kaiwen Wu, Mengzhuo Li, Shanan Chen, Zijian Wu, Zhipeng Yu und 2 weitere

Advanced Healthcare Materials · 2026-05 · 15 (20)

DOI: 10.1002/adhm.202505897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 23.03.2026. Verfasst von Zekun Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Food Colloids and Delivery of Functionality, College of Food Science and Nutritional Engineering, China Agricultural University, B…. Hauptthemen laut MEDLINE: Uric Acid, Probiotics, Quercetin, Polysaccharides. Die Arbeit nennt 74 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Nova Program, Pinduoduo-China Agricultural University Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperuricemia (HUA), a metabolic disorder associated with inflammatory and gut microbiota dysbiosis, demands effective intestinal‐targeted therapies. Herein, a novel intestinal‐targeted delivery system was designed based on quercetin nanorods coated Lactobacillus paracasei MC1 encapsulated within manganese‐crosslinked Mesona chinensis polysaccharide microgels (MCPM‐QUE‐MC1). The MC1 strain, isolated from the traditional fermented food “Jiangshui”, exhibits potent uric acid‐degrading activity. The quercetin nanocoating enhances mucosal adhesion and antioxidative capacity through a prebiotic nanointerface, while manganese ions impart nanozyme‐like catalytic activity, scavenging hydrogen peroxide (H 2 O 2 ) and modulating the intestinal microenvironment. This synergistic assembly protects probiotics from gastric acidity and promotes intestinal colonization, as validated in mouse and pig models. In HUA mice, oral administration of MCPM‐QUE‐MC1 significantly reduced serum uric acid levels to 101.83 ± 6.88 µmol L −1 , increased MC1 abundance by 8.37‐fold, improved renal function, suppressed inflammatory cytokines, and restored gut microbial homeostasis by notably enriching short‐chain fatty acid‐producing bacteria. Mechanistically, the therapeutic effect arises from enhanced uric acid degradation, inhibition of hepatic xanthine oxidase, reduction of intestinal permeability, and systemic endotoxemia. Overall, this study establishes a promising probiotic‐polyphenol prebiotic‐microgel composite platform for HUA alleviation, offering a new insight into gut microbiota‐targeted therapies for metabolic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uric AcidProbioticsQuercetinPolysaccharidesHyperuricemiaMicrogelsAnimalsMiceSwineGastrointestinal MicrobiomeMaleLactobacillusNanotubes

Stichwörter der Autor:innen

anti‐hyperuricemiadelivery systemgut microbiotananocoatingpolysaccharide microgelsprobiotics

Substanzen

Uric AcidQuercetinPolysaccharidesMicrogels

Autor:innen und Institutionen

  • Research Center of Food Colloids and Delivery of Functionality, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
  • College of Food Science and Engineering, Tianjin University of Science & Technology, Tianjin, China.
  • Department of Mechanical Engineering, Polymer Technology, Eindhoven University of Technology, Eindhoven, The Netherlands.
  • Key Laboratory of Renal Disease, Ministry of Health of China, Peking University First Hospital, Beijing, China.
  • Dairy Nutrition and Function, Key Laboratory of Sichuan Province, New Hope Dairy Co., ltd., Chengdu, China.
  • School of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin, China.

ORCID-Profile: Yuan Li

Förderung

  • National Natural Science Foundation of China
  • Beijing Nova Program
  • Pinduoduo-China Agricultural University Research Fund

Zitieren

APA

Li, Z., Ma, Z., Zhao, D., Poortinga, A., Wang, X., Zhang, Y., Yue, Q., Wu, K., Li, M., Chen, S., Wu, Z., Yu, Z., Wen, P., & Li, Y. (2026). The Uric Acid Degrading Probiotics MC1 in Quercetin Nanocoatings and Bioactive Polysaccharides Microgels for Anti‐Hyperuricemia and Gut Microenvironment Modulation. Advanced Healthcare Materials, 15(20). https://doi.org/10.1002/adhm.202505897

Vancouver

Li Z, Ma Z, Zhao D, Poortinga A, Wang X, Zhang Y, et al. The Uric Acid Degrading Probiotics MC1 in Quercetin Nanocoatings and Bioactive Polysaccharides Microgels for Anti‐Hyperuricemia and Gut Microenvironment Modulation. Advanced Healthcare Materials. 2026;15(20). doi:10.1002/adhm.202505897

BibTeX
@article{Li2026,
  author = {Li, Zekun and Ma, Zhaoxiang and Zhao, Dongyu and Poortinga, Albert and Wang, Xiaoyu and Zhang, Yuemiao and Yue, Qing and Wu, Kaiwen and Li, Mengzhuo and Chen, Shanan and Wu, Zijian and Yu, Zhipeng and Wen, Pengcheng and Li, Yuan},
  title = {The Uric Acid Degrading Probiotics MC1 in Quercetin Nanocoatings and Bioactive Polysaccharides Microgels for Anti‐Hyperuricemia and Gut Microenvironment Modulation},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {20},
  doi = {10.1002/adhm.202505897}
}
Kostenlos starten →